Evidence map›Paper›PMID 40162487›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

In Situ Control of Reactive Mesogens Alignment During 3D Printing by Two-Photon Lithography.

Tiziana Ritacco, Alfredo Mazzulla, Michele Giocondo, Gabriella Cipparrone, Pasquale Pagliusi

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. In Situ Control of Reactive Mesogens Alignment During 3D Printing by Two-Photon Lithography.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tiziana RitaccoDepartment of Physics, University of Calabria, Rende (CS), 87036, Italy.ORCID https://orcid.org/0000-0001-5036-2518
Alfredo MazzullaCNR Nanotec - Institute of Nanotechnology, S.S. Cosenza, Rende (CS), 87036, Italy.ORCID https://orcid.org/0000-0002-1938-3959
Michele GiocondoCNR Nanotec - Institute of Nanotechnology, S.S. Cosenza, Rende (CS), 87036, Italy.ORCID https://orcid.org/0000-0002-5018-0834
Gabriella CipparroneDepartment of Physics, University of Calabria, Rende (CS), 87036, Italy.ORCID https://orcid.org/0000-0003-4880-1942
Pasquale PagliusiDepartment of Physics, University of Calabria, Rende (CS), 87036, Italy.ORCID https://orcid.org/0000-0001-8077-816X

Funding

Ministero dell'Università e della Ricerca ARS01_00401-CUP: B24I20000080001
6 · The paper itself

Abstract

Photopolymerizable liquid crystals, also known as reactive mesogens, are leading candidates for additive manufacturing of smart microdevices via two-photon lithography (TPL). While substantial advancements are made toward innovative applications, precise control of molecular alignment during fabrication, essential for tailoring complex optical and mechanical responses, remains a significant challenge. Current solutions require elaborate multi-step procedures or customized setups to achieve 2D or 3D alignment patterns. Herein, the deterministic effect of TPL on the orientation of mesogenic moieties is reported, under optimized printing conditions. Specifically, a single-step simple method is developed for aligning the nematic director in situ, with sub-diffraction-limited resolution, during 3D printing. Based on the conventional TPL workflow, the "director-tuning mode" (DiTuM) relies on the anisotropic photopolymerization reaction occurring along the print path at low laser scan speeds (≈0.1mm s

Indexed as

3D Printingadditive manufacturinganti‐counterfeitingliquid crystalstunable alignment

Identifiers

PMID40162487
PMCPMC12140314

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.